News
Art, architecture and design news. Criticism and reviews from co-chief art critics Roberta Smith and Holland Cotter and architecture critic Michael Kimmelman.
Eli Lilly's oral tau drug fails to show efficacy in a phase 2 trial in Alzheimer's disease in another setback for the class ...
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
From Ed Atkins’ knockout Tate Britain retrospective to an Paul Thek exhibition curated by Jonathan Anderson, and a survey of a long-overlooked late queer artist, Hamad Butt, these are the art ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results